We are live on ! Find out more
SI

Sofinnova Investments Portfolio holdings

AUM $2.63B
1-Year Est. Return 117.41%
This Fund
S&P 500
This Quarter Est. Return
+35.89%
1 Year Est. Return
+117.41%
3 Year Est. Return
+428.82%
5 Year Est. Return
+748.21%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$7.91M
Cap. Flow
-$287M
Cap. Flow %
-15.97%
Top 10 Hldgs %
51.42%
Holding
93
New
31
Increased
19
Reduced
14
Closed
21

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$72.8M
2
INCY icon
Incyte
INCY
+$61.9M
3
IDXX icon
Idexx Laboratories
IDXX
+$41.1M
4
ARGX icon
argenx
ARGX
+$40.5M
5
PODD icon
Insulet
PODD
+$37.5M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$437M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$150M
3
IMGN
Immunogen Inc
IMGN
+$45.9M
4
LLY icon
Eli Lilly
LLY
+$37.6M
5
CYTK icon
Cytokinetics
CYTK
+$34.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.6%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FULC icon
76
Fulcrum Therapeutics
FULC
$248M
– –
-28,600
Closed -$193K
GERN icon
77
Geron
GERN
$930M
– –
-8,814,497
Closed -$18.6M
IMVT icon
78
Immunovant
IMVT
$7.99B
– –
-222,553
Closed -$9.38M
IRWD icon
79
Ironwood Pharmaceuticals
IRWD
$626M
– –
-331,099
Closed -$3.79M
KVUE icon
80
Kenvue
KVUE
$37.9B
– –
-1,206,939
Closed -$26M
LLY icon
81
Eli Lilly
LLY
$1.09T
– –
-64,525
Closed -$37.6M
MLTX icon
82
MoonLake Immunotherapeutics
MLTX
$1.59B
– –
-113,757
Closed -$6.87M
PEN icon
83
Penumbra
PEN
$12.6B
– –
-2,000
Closed -$503K
SNY icon
84
Sanofi
SNY
$109B
– –
-598,978
Closed -$29.8M
SYK icon
85
Stryker
SYK
$133B
– –
-62,788
Closed -$18.8M
VIR icon
86
Vir Biotechnology
VIR
$1.49B
– –
-4,495
Closed -$45.2K
SPRB
87
Spruce Biosciences
SPRB
$114M
– –
-304
Closed -$66.7K
GRTX
88
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
– –
-3,083,712
Closed -$448K
CBAY
89
DELISTED
Cymabay Therapeutics
CBAY
– –
-1,411,769
Closed -$33.3M
KRTX
90
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-1,381,149
Closed -$437M
RYZB
91
DELISTED
RayzeBio, Inc. Common Stock
RYZB
– –
-2,419,528
Closed -$150M
IMGN
92
DELISTED
Immunogen Inc
IMGN
– –
-1,546,902
Closed -$45.9M
1 2 3
4

Similar funds

WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Sofinnova Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Sofinnova Investments held 93 positions worth $1.8B, up 0.44% from $1.79B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sofinnova Investments withdrew a net $287M in Q1 2024, closing 21 positions and reducing 14 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $437M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Consumer Staples.

Against the trend, Sofinnova Investments opened a new position in Novo Nordisk worth $78.6M.

  • Sofinnova Investments's largest Q1 2024 buy was Novo Nordisk: 611,884 shares worth $78.6M.
  • Sofinnova Investments added most to Incyte in Q1 2024, an estimated $61.9M increase.
  • Sofinnova Investments's biggest Q1 2024 reduction was IDEAYA Biosciences, cutting an estimated $29.1M.
  • Sofinnova Investments fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $437M.
  • Sofinnova Investments's ten largest holdings make up 51% of its $1.8B portfolio in Q1 2024.
  • Sofinnova Investments opened 31 new positions and closed 21 in Q1 2024.
  • Sofinnova Investments's portfolio value rose 0.44% quarter-over-quarter to $1.8B.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.